Skip to main content
Erschienen in: Cancer Chemotherapy and Pharmacology 2/2014

01.08.2014 | Original Article

Cimetidine attenuates vinorelbine-induced phlebitis in mice by militating E-selectin expression

verfasst von: Zhuo Wang, Lijuan Ma, Xuebin Wang, Heping Cai, Jin Huang, Jiyong Liu, Jinhong Hu, Dingfeng Su

Erschienen in: Cancer Chemotherapy and Pharmacology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We investigated E-selectin expression in mice and rabbits with vinorelbine-induced phlebitis and the effect of cimetidine. To find the relationship between E-selectin expression and vinorelbine-induced phlebitis.

Methods

Mouse and rabbit model of vinorelbine-induced phlebitis was established by intravenous infusion of vinorelbine. Pathological observation, molecular-biological determination of E-selectin and protein function of it was evaluated.

Results

Grossly, we observed swelling, edema and cord-like vessel changes in mice receiving vinorelbine but only mild edema in mice pretreated with cimetidine. Pathological scoring yielded a total score of 37 for vinorelbine-treated mice and 17 for mice pretreated with cimetidine (P < 0.05). ELISA revealed that rabbits treated with vinorelbine had markedly higher serum contents of E-selectin than normal saline (NS) controls (vinorelbine 1.534 ± 0.449 vs. NS 0.746 ± 0.170 ng/mL, P < 0.05), which was markedly attenuated by cimetidine (cimetidine 0.717 ± 0.468 vs. vinorelbine 1.534 ± 0.449 ng/mL, P < 0.05). Rose Bengal staining assays showed that vinorelbine markedly increased the adhesion rate of neutrophils for endothelial cells (vinorelbine 38.70 ± 8.34 % vs. controls 8.93 ± 4.85 %, P < 0.01), which, however, was significantly suppressed by cimetidine (9.93 ± 5.91 %, P < 0.01 vs. vinorelbine). In E-selectin knockout mice, we found no apparent difference in tail swelling in mice receiving vinorelbine or cimetidine and vinorelbine.

Conclusions

In conclusion, cimetidine attenuates vinorelbine-induced phlebitis in mice probably by suppressing increased expression of E-selectin.
Literatur
1.
Zurück zum Zitat Myrianthefs P, Karatzas S, Baltopoulos G (2005) Complications, thrombophlebitis rates, and intravenous catheter replacement strategies. Infection 33:96–97PubMedCrossRef Myrianthefs P, Karatzas S, Baltopoulos G (2005) Complications, thrombophlebitis rates, and intravenous catheter replacement strategies. Infection 33:96–97PubMedCrossRef
2.
Zurück zum Zitat Tagalakis V, Kahn SR, Libman M et al (2002) The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. Am J Med 113:146–151PubMedCrossRef Tagalakis V, Kahn SR, Libman M et al (2002) The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. Am J Med 113:146–151PubMedCrossRef
3.
Zurück zum Zitat Myrianthefs P, Sifaki M, Samara I et al (2005) The epidemiology of peripheral vein complications: evaluation of the efficiency of differing methods for the maintenance of catheter patency and thrombophlebitis prevention. J Eval Clin Pract 11:85–89PubMedCrossRef Myrianthefs P, Sifaki M, Samara I et al (2005) The epidemiology of peripheral vein complications: evaluation of the efficiency of differing methods for the maintenance of catheter patency and thrombophlebitis prevention. J Eval Clin Pract 11:85–89PubMedCrossRef
4.
Zurück zum Zitat Lanbeck P, Odenholt I, Paulsen O (2003) Dicloxacillin: a higher risk than cloxacillin for infusion phlebitis. Scand J Infect Dis 35:397–400PubMedCrossRef Lanbeck P, Odenholt I, Paulsen O (2003) Dicloxacillin: a higher risk than cloxacillin for infusion phlebitis. Scand J Infect Dis 35:397–400PubMedCrossRef
5.
Zurück zum Zitat Suga Y, Kumazaki M, Nishigami J et al (2009) Improvement of epirubicin-induced phlebitis to switch from liquid preparation to lyophilized formulation. Gan To Kagaku Ryoho 36:93–96PubMed Suga Y, Kumazaki M, Nishigami J et al (2009) Improvement of epirubicin-induced phlebitis to switch from liquid preparation to lyophilized formulation. Gan To Kagaku Ryoho 36:93–96PubMed
6.
Zurück zum Zitat Simamora P, Pinsuwan S, Alvarez JM et al (1995) Effect of pH on injection phlebitis. J Pharm Sci 84:520–521PubMedCrossRef Simamora P, Pinsuwan S, Alvarez JM et al (1995) Effect of pH on injection phlebitis. J Pharm Sci 84:520–521PubMedCrossRef
7.
Zurück zum Zitat Kilic B, Kruse M, Stahlmann R (2006) The in vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926). Toxicology 218:30–38PubMedCrossRef Kilic B, Kruse M, Stahlmann R (2006) The in vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926). Toxicology 218:30–38PubMedCrossRef
8.
Zurück zum Zitat Curran CF, Luce JK, Page JA (1990) Doxorubicin-associated flare reactions. Oncol Nurs Forum 17:387–389PubMed Curran CF, Luce JK, Page JA (1990) Doxorubicin-associated flare reactions. Oncol Nurs Forum 17:387–389PubMed
9.
Zurück zum Zitat Juergens R, Brahmer J, Ettinger D (2007) Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter. Cancer Chemother Pharmacol 59:621–629PubMedCrossRef Juergens R, Brahmer J, Ettinger D (2007) Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter. Cancer Chemother Pharmacol 59:621–629PubMedCrossRef
10.
Zurück zum Zitat Kelly K, Crowley J, Bunn PA Jr et al (2001) Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial. J Clin Oncol 19:3210–3218PubMed Kelly K, Crowley J, Bunn PA Jr et al (2001) Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial. J Clin Oncol 19:3210–3218PubMed
11.
Zurück zum Zitat Yoh K, Niho S, Goto K et al (2007) Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity. Lung Cancer 55:337–341PubMedCrossRef Yoh K, Niho S, Goto K et al (2007) Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity. Lung Cancer 55:337–341PubMedCrossRef
12.
Zurück zum Zitat de Lemos ML (2005) Vinorelbine and venous irritation: optimal parenteral administration. J Oncol Pharm Pract 11:79–81PubMedCrossRef de Lemos ML (2005) Vinorelbine and venous irritation: optimal parenteral administration. J Oncol Pharm Pract 11:79–81PubMedCrossRef
13.
Zurück zum Zitat Brimblecombe RW, Duncan WA, Durant GJ et al (1975) The pharmacology of cimetidine, a new histamine H2-receptor antagonist. Br J Clin Pharmacol 53:435–436 Brimblecombe RW, Duncan WA, Durant GJ et al (1975) The pharmacology of cimetidine, a new histamine H2-receptor antagonist. Br J Clin Pharmacol 53:435–436
14.
Zurück zum Zitat Kubecova M, Kolostova K, Pinterova D (2011) Cimetidine: an anticancer drug? Eur J Pharm Sci 42:439–444PubMedCrossRef Kubecova M, Kolostova K, Pinterova D (2011) Cimetidine: an anticancer drug? Eur J Pharm Sci 42:439–444PubMedCrossRef
15.
Zurück zum Zitat Vassilomanolakis M, Koumakis G, Barbounis V et al (2001) Prevention of vinorelbine phlebitis with cimetidine: a two-step design study. Support Care Cancer 9:108–111PubMedCrossRef Vassilomanolakis M, Koumakis G, Barbounis V et al (2001) Prevention of vinorelbine phlebitis with cimetidine: a two-step design study. Support Care Cancer 9:108–111PubMedCrossRef
16.
Zurück zum Zitat Liu FR, Jiang CG, Li YS et al (2011) Cimetidine inhibits the adhesion of gastric cancer cells expressing high levels of sialyl Lewis x in human vascular endothelial cells by blocking E-selectin expression. Int J Mol Med 27:537–544PubMed Liu FR, Jiang CG, Li YS et al (2011) Cimetidine inhibits the adhesion of gastric cancer cells expressing high levels of sialyl Lewis x in human vascular endothelial cells by blocking E-selectin expression. Int J Mol Med 27:537–544PubMed
17.
Zurück zum Zitat Kobayashi K, Matsumoto S, Morishina T et al (2000) Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer Res 60(14):3978–3984PubMed Kobayashi K, Matsumoto S, Morishina T et al (2000) Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer Res 60(14):3978–3984PubMed
18.
Zurück zum Zitat Bevilacqua MP, Stengelin S, Gimbrone MA Jr et al (1989) Endothelial leukocyte adhesion molecule: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243:1160–1165PubMedCrossRef Bevilacqua MP, Stengelin S, Gimbrone MA Jr et al (1989) Endothelial leukocyte adhesion molecule: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243:1160–1165PubMedCrossRef
19.
Zurück zum Zitat Sriramarao P, Norton CR, Borgstrom P et al (1996) E-selectin preferentially supports neutrophil but not eosinophil rolling under condition of flow in vitro and in vivo. J Immunol 157:4672–4680PubMed Sriramarao P, Norton CR, Borgstrom P et al (1996) E-selectin preferentially supports neutrophil but not eosinophil rolling under condition of flow in vitro and in vivo. J Immunol 157:4672–4680PubMed
20.
Zurück zum Zitat Pan D, Han J, Wilburn P, Rockson SG (2006) Validation of a new technique for the quantitation of edema in the experimental setting. Lymphat Res Biol 4:153–158PubMedCrossRef Pan D, Han J, Wilburn P, Rockson SG (2006) Validation of a new technique for the quantitation of edema in the experimental setting. Lymphat Res Biol 4:153–158PubMedCrossRef
21.
Zurück zum Zitat al-Swayeh OA, Clifford RH, del Soldato P, Moore PK (2000) A comparison of the anti-inflammatory and anti-nociceptive activity of nitroaspirin and aspirin. Br J Pharmacol 129:343–350PubMedCentralPubMedCrossRef al-Swayeh OA, Clifford RH, del Soldato P, Moore PK (2000) A comparison of the anti-inflammatory and anti-nociceptive activity of nitroaspirin and aspirin. Br J Pharmacol 129:343–350PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Kuwahara T, Asanami S, Kubo S (1998) Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells. Nutrition 14:496–501PubMedCrossRef Kuwahara T, Asanami S, Kubo S (1998) Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells. Nutrition 14:496–501PubMedCrossRef
23.
Zurück zum Zitat Kuwahara T, Asanami S, Kubo S (1998) Dilution is effective in reducing infusion phlebitis in peripheral parenteral nutrition: an experimental study in rabbits. Nutrition 14:186–190PubMedCrossRef Kuwahara T, Asanami S, Kubo S (1998) Dilution is effective in reducing infusion phlebitis in peripheral parenteral nutrition: an experimental study in rabbits. Nutrition 14:186–190PubMedCrossRef
24.
Zurück zum Zitat Gamble JR, Vadas MA (1988) A new assay for the measurement of the attachment of neutrophils and other cell types to endothelial cells. J Immunol Methods 109:175–184PubMedCrossRef Gamble JR, Vadas MA (1988) A new assay for the measurement of the attachment of neutrophils and other cell types to endothelial cells. J Immunol Methods 109:175–184PubMedCrossRef
25.
Zurück zum Zitat Yoh K, Niho S, Goto K et al (2007) Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity. Lung Cancer 55:337–341PubMedCrossRef Yoh K, Niho S, Goto K et al (2007) Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity. Lung Cancer 55:337–341PubMedCrossRef
26.
Zurück zum Zitat de Lemos ML (2005) Vinorelbine and venous irritation: optimal parenteral administration. J Oncol Pharm Pract 11:79–81PubMedCrossRef de Lemos ML (2005) Vinorelbine and venous irritation: optimal parenteral administration. J Oncol Pharm Pract 11:79–81PubMedCrossRef
27.
Zurück zum Zitat Eppihimer MJ, Schaub RG (2001) Soluble P-selectin antagonist mediates rolling velocity and adhesion of leukocytes in acutely inflamed venules. Microcirculation 8:15–24PubMedCrossRef Eppihimer MJ, Schaub RG (2001) Soluble P-selectin antagonist mediates rolling velocity and adhesion of leukocytes in acutely inflamed venules. Microcirculation 8:15–24PubMedCrossRef
28.
Zurück zum Zitat Lanbeck P, Odenholt I, Riesbeck K (2004) Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis. J Antimicrob Chemother 53:174–179PubMedCrossRef Lanbeck P, Odenholt I, Riesbeck K (2004) Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis. J Antimicrob Chemother 53:174–179PubMedCrossRef
29.
Zurück zum Zitat Ma LJ, Wang Z, Hu JH (2009) Preventive effect of cimetidine on infusion phlebitis induced by vinorelbine. Pharm Care & Res 9:340–343 Ma LJ, Wang Z, Hu JH (2009) Preventive effect of cimetidine on infusion phlebitis induced by vinorelbine. Pharm Care & Res 9:340–343
30.
Zurück zum Zitat Forlow SB, White EJ, Barlow SC et al (2000) Severe inflammatory defect and reduced viability in CD18 and E-selectin double-mutant mice. J Clin Invest 106:1457–1466PubMedCentralPubMedCrossRef Forlow SB, White EJ, Barlow SC et al (2000) Severe inflammatory defect and reduced viability in CD18 and E-selectin double-mutant mice. J Clin Invest 106:1457–1466PubMedCentralPubMedCrossRef
31.
Zurück zum Zitat Bevilacqua MP, Stengelin S, Gimbrone MA Jr et al (1989) Endothelial leukocyte adhesion molecule: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243:1160–1165PubMedCrossRef Bevilacqua MP, Stengelin S, Gimbrone MA Jr et al (1989) Endothelial leukocyte adhesion molecule: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243:1160–1165PubMedCrossRef
32.
Zurück zum Zitat Motsumoto S, Imaeda Y, Umemoto S et al (2002) Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells. Br J Cancer 86:159–160CrossRef Motsumoto S, Imaeda Y, Umemoto S et al (2002) Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells. Br J Cancer 86:159–160CrossRef
33.
Zurück zum Zitat Kobayashi K, Matsumoto S, Morishina T et al (2000) Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer Res 60:3978–3984PubMed Kobayashi K, Matsumoto S, Morishina T et al (2000) Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer Res 60:3978–3984PubMed
34.
Zurück zum Zitat Kawase J, Kobayashi K, Imaeda Y et al (2005) An interesting change of E-selectin in cimetidine administration during anticancer drug use. Gan To Kagaku Ryoho 32:1578–1579PubMed Kawase J, Kobayashi K, Imaeda Y et al (2005) An interesting change of E-selectin in cimetidine administration during anticancer drug use. Gan To Kagaku Ryoho 32:1578–1579PubMed
35.
Zurück zum Zitat Kawase J, Ozawa S, Kobayashi K et al (2009) Increase in E-selectin expression in umbilical vein endothelial cells by anticancer drugs and inhibition by cimetidine. Oncol Rep 22:1293–1297PubMed Kawase J, Ozawa S, Kobayashi K et al (2009) Increase in E-selectin expression in umbilical vein endothelial cells by anticancer drugs and inhibition by cimetidine. Oncol Rep 22:1293–1297PubMed
Metadaten
Titel
Cimetidine attenuates vinorelbine-induced phlebitis in mice by militating E-selectin expression
verfasst von
Zhuo Wang
Lijuan Ma
Xuebin Wang
Heping Cai
Jin Huang
Jiyong Liu
Jinhong Hu
Dingfeng Su
Publikationsdatum
01.08.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Cancer Chemotherapy and Pharmacology / Ausgabe 2/2014
Print ISSN: 0344-5704
Elektronische ISSN: 1432-0843
DOI
https://doi.org/10.1007/s00280-014-2487-8

Weitere Artikel der Ausgabe 2/2014

Cancer Chemotherapy and Pharmacology 2/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.